DEA: telehealth rules for Adderall, buprenorphine, controlled meds

The US Department of Health and Human Services and DEA published rules on telemedicine prescribing of controlled substances, including a special registration proposed rule and a final rule on telemedicine prescribing of buprenorphine. Practitioners can prescribe a 6-month supply of Schedule III-V medications to treat opioid use disorder via audio without in-person evaluation.